These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 377825)
1. The etiology of chronic active hepatitis in Korea. Prince AM; Gershon RK Yale J Biol Med; 1979; 52(2):159-67. PubMed ID: 377825 [TBL] [Abstract][Full Text] [Related]
2. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state. Feinman SV; Berris B; Cooter N; Sinclair JC; Wrobel DM Hepatogastroenterology; 1982 Apr; 29(2):58-61. PubMed ID: 7084885 [TBL] [Abstract][Full Text] [Related]
3. Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage. Alberti A; Diana S; Scullard GH; Eddleston WF; Williams R Gastroenterology; 1978 Nov; 75(5):869-74. PubMed ID: 700329 [TBL] [Abstract][Full Text] [Related]
4. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Liaw YF; Sheen IS; Chen TJ; Chu CM; Pao CC Hepatology; 1991 Apr; 13(4):627-31. PubMed ID: 2010157 [TBL] [Abstract][Full Text] [Related]
5. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection. Perrillo R; Campbell C; Wellinghoff W; Gelb L Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131 [TBL] [Abstract][Full Text] [Related]
6. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood. Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948 [TBL] [Abstract][Full Text] [Related]
7. The significance of the Australia antigen (HBsAg) persistent healthy carrier "status": a long-term follow-up study of 34 cases. Piccinino F; Manzillo G; Sagnelli E; Balestrieri GG; Maio G; Pasquale G; Felaco FM Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):171-8. PubMed ID: 665117 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
9. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378 [TBL] [Abstract][Full Text] [Related]
10. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Colombo M; Cambieri R; Rumi MG; Ronchi G; Del Ninno E; De Franchis R Gastroenterology; 1983 Aug; 85(2):235-9. PubMed ID: 6345255 [TBL] [Abstract][Full Text] [Related]
11. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV. De Franchis R; D'Arminio A; Vecchi M; Ronchi G; Del Ninno E; Parravicini A; Ferroni P; Zanetti AR Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112 [TBL] [Abstract][Full Text] [Related]
12. [Infection due to hepatitis B virus and host immune response]. Realdi G; Bortolotti F; Alberti A; Fattovich G; Ongaro G Boll Ist Sieroter Milan; 1976 Sep; 55(4):323-34. PubMed ID: 1016586 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen carriers--to biopsy or not to biopsy. Koretz RL; Lewin KJ; Rebhun DJ; Gitnick GL Gastroenterology; 1978 Nov; 75(5):860-3. PubMed ID: 700327 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity? Gessoni G; Manoni F Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245 [TBL] [Abstract][Full Text] [Related]
15. Laparoscopical and histological abnormalities of the liver in chronic HBs ag (hepatitis B surface antigen) carriers. Iwamura K Tokai J Exp Clin Med; 1982 Jan; 7(1):43-51. PubMed ID: 6210975 [TBL] [Abstract][Full Text] [Related]
17. Large molecular form of serum HBeAg in chronic hepatitis B virus infection: relation to liver cell damage. Kurai K; Iino S; Kurokawa K; Shimoda K; Hino K Hepatology; 1991 Jun; 13(6):1057-60. PubMed ID: 2050322 [TBL] [Abstract][Full Text] [Related]
18. [Frequency of antigen associated to hepatitis due to virus B (HBAg) and of antibody (HBAc) in healthy subjects and during of course of acute and chronic hepatitis. Radioimmunologic study]. Realdi G; Tremolada F; Alberti A; Rigoli A; Diodati G; Visconti M Quad Sclavo Diagn; 1975 Jun; 11(2):419-30. PubMed ID: 1223946 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B core antigen immune complexes in the liver of hepatitis B patients. Ray MB; Desmet VJ; Bradburne AF; Desmyter J; Fevery J; De Groote J Clin Exp Immunol; 1979 Jul; 37(1):15-24. PubMed ID: 385186 [TBL] [Abstract][Full Text] [Related]
20. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]